Clinical Trials Logo

Filter by:
NCT ID: NCT05057377 Completed - Clinical trials for Brain Injuries, Traumatic

Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury

Start date: September 22, 2021
Phase:
Study type: Observational

Traumatic brain injury (TBI) due to trauma and/or neurologic disease is a leading cause of long-term disability in the United States. The loss of balance for people with a traumatic brain injury can have a large effect on their walking abilities and this can come with a number of challenges. There is a greater risk of falling after being discharged from the hospital. In addition, people are more likely to become sedentary after TBI, which leads to the loss of muscle strength. To help provide the best care, clinicians need accurate measurements when people begin their therapy, as well as throughout to ensure they are making appropriate progress. The tests currently used by clinicians may not provide the most accurate measurements that show what a person is capable of physically doing. The study you are being asked to participate in aims to provide more accurate measurements by using a robotic treadmill device and by assessing motivating factors that are important to you. The treadmill device will allow us to more accurately test your walking ability in a safe, fall-free environment.

NCT ID: NCT05057364 Completed - Heart Failure Clinical Trials

Heart Smart: A Virtual Self-Management Program for Homebound People With Heart Failure

Start date: September 28, 2021
Phase: N/A
Study type: Interventional

The purpose of this capstone project is to pilot Heart Smart, a virtual group program to improve self-efficacy for self-management skills for homebound people with heart failure.

NCT ID: NCT05056870 Completed - Visual Acuity Clinical Trials

Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats

Start date: September 15, 2021
Phase: N/A
Study type: Interventional

This will be a 5-visit, randomized, partially single-masked, bilateral wear, dispensing, 2-treatment × 2-period crossover study with spectacle-wear washout and wash-in periods.

NCT ID: NCT05056753 Completed - Opioid-use Disorder Clinical Trials

Heterodyned Whole-Body Vibration in Treatment of Opioid Withdrawal-Induced Anxiety

Start date: January 20, 2022
Phase: N/A
Study type: Interventional

In this randomized, double-blind, controlled, parallel group study (conducted over 12-months), enrollment is expected of up to 60 subjects (30 men and 30 women) ages 18+ who are currently going through withdrawal of OUD and being treated at local substance abuse clinics. The study visits will include screening, baseline, Weeks 1, 2, 3, and 4, with both safety and efficacy assessments.

NCT ID: NCT05056480 Completed - Care Coordination Clinical Trials

Learning Health for Pediatric Complex Care Integration (PCCI)

Start date: March 24, 2021
Phase:
Study type: Observational

The study team will conduct a mixed methods evaluation of the implementation of an evidence-based clinical program -- the Pediatric Complex Care Integration (PCCI) program - for improvement of care integration for children and youth with special healthcare needs (CYSHCN) and children with medical complexity (CMC). The PCCI program is not a discrete intervention itself; rather it is a health system-initiated program that will be implemented as a new standard of care for eligible patients with the intention of improving quality of care, implemented by clinical teams within Duke Health.

NCT ID: NCT05056311 Completed - Hypospadias Clinical Trials

Engaging Families to Improve the Care of Patients With Hypospadias

Start date: June 9, 2021
Phase: N/A
Study type: Interventional

Reconstructive surgery is advocated for most children with hypospadias, a condition in which the pee hold is not in the correct place on the penis, to prevent potentially serious cosmetic and functional problems. Parents faced with a decision about hypospadias repair encounter an irreversible choice with potentially lifelong consequences. Recent studies have identified decisional conflict (DC) and decisional regret (DR) as a significant problem for parents. Several recent guidelines on complex urologic topics suggest that shared decision-making (SDM) is the optimal approach. A pilot test of a decision aid website by parents potentially facing this decision will be conducted to measure pre- and post-outcomes, in order to develop a fuller understanding of how urologists can effectively provide parents with optimal decision support. Parents will answer questions via phone up to four time points, twice before (T1 and T2) and twice after seeing a urologist for a hypospadias referral (T3 and T4). If the urologist diagnoses hypospadias but recommends no surgery, the final data collection point will be three months after the urology visit. If the urologist recommends repair surgery, the final data collection point will be six months after surgery.

NCT ID: NCT05056246 Completed - Clinical trials for Healthy Participants

Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants

Start date: September 28, 2021
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the pharmacokinetics (PK) of AMG 133 after single subcutaneous (SC) administration in healthy Japanese and Caucasian participants.

NCT ID: NCT05056155 Completed - Dry Eye Disease Clinical Trials

Systane Complete Multi-symptom Relief

Start date: November 9, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate effective symptom relief with the use of Systane Complete among subjects with dry eye disease (DED).

NCT ID: NCT05055778 Completed - Smoking Cessation Clinical Trials

Establishing the Effectiveness of Publicly Available Smoking Cessation Resource

Start date: November 3, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of SmokefreeTXT, a smoking cessation text messaging program currently available to anyone in the United States through www.smokefree.gov, and to compare cessation outcomes for smokers living in different regions of Virginia while participants use the program. Participants will be asked to complete assessments at Baseline, 7 weeks, 3 months, and 6 months and will be asked to use a research version of SmokefreeTXT.

NCT ID: NCT05055752 Completed - Bioequivalence Clinical Trials

Randomized, Crossover Bioequivalence Study of PL-ASA Versus Immediate Release Aspirin in Healthy Volunteers.

Start date: May 7, 2020
Phase: Phase 1
Study type: Interventional

This trial is a randomized, actively-controlled, open-label, 2-way crossover bioequivalence study to determine PK parameters following treatment with test aspirin product (PL-ASA capsules) and reference aspirin product (IR-ASA tablets) administered at a single dose of 325 mg.